Literature DB >> 17767557

The nature of diversity of HLA-DRB1 exon 3.

P A Horn1, M Albis-Camps, M Verboom, M Bunce, K Yousaf, S Williams, R Blasczyk.   

Abstract

Exon 3 of DRB1 is known to be polymorphic, but thought to be conserved within allelic groups. This implies that exon 3 polymorphisms would not need to be considered in evolutionary studies or clinical settings when assessing immunogenicity of allelic mismatches in stem cell transplantation. To further assess this, we determined the sequences of DRB1 exon 3 by hemizygote amplification and direct sequencing on 55 selected DNA samples containing 42 DRB1 alleles for which no exon 3 sequence data were previously available. The data confirmed the high degree of overall sequence conservation. The DRB4- and DRB5-associated alleles were completely conserved within their DRB1 groups. However, it could be shown that exon 3 is more diverse than previously expected. Multiple allelic differences within each group of DRB3-associated DRB1 alleles were found, without identifying unique group-related sequence motifs differentiating between these groups. For DRB1*1402 and DRB1*1406, it could be shown that they originated from DRB1*0302. In several samples previously typed as DRB1*1401, a novel DRB1 allele was identified: DRB1*1454. Thus, from a clinical viewpoint, the availability of exon 3 sequence information may be useful for optimizing typing as well as matching strategies. Additionally, it will allow for more detailed evolutionary studies, further elucidating the origin of alleles and the mechanisms driving sequence diversification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767557     DOI: 10.1111/j.1399-0039.2007.00918.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

Review 1.  Nomenclature for factors of the HLA system, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Tissue Antigens       Date:  2010-04

2.  Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101.

Authors:  Y Xiao; A M Lazaro; C Masaberg; M Haagenson; C Vierra-Green; S Spellman; S Dakshanamurthy; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2009-04-06

3.  Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Authors:  S J Mack; P Cano; J A Hollenbach; J He; C K Hurley; D Middleton; M E Moraes; S E Pereira; J H Kempenich; E F Reed; M Setterholm; A G Smith; M G Tilanus; M Torres; M D Varney; C E M Voorter; G F Fischer; K Fleischhauer; D Goodridge; W Klitz; A-M Little; M Maiers; S G E Marsh; C R Müller; H Noreen; E H Rozemuller; A Sanchez-Mazas; D Senitzer; E Trachtenberg; Marcelo Fernandez-Vina
Journal:  Tissue Antigens       Date:  2013-04

4.  High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program.

Authors:  Xiao-Yang Zhou; Fa-Ming Zhu; Jian-Ping Li; Wei Mao; De-Mei Zhang; Meng-Li Liu; Ai-Lian Hei; Da-Peng Dai; Ping Jiang; Xiao-Yan Shan; Bo-Wei Zhang; Chuan-Fu Zhu; Jie Shen; Zhi-Hui Deng; Zheng-Lei Wang; Wei-Jian Yu; Qiang Chen; Yan-Hui Qiao; Xiang-Ming Zhu; Rong Lv; Guo-Ying Li; Guo-Liang Li; Heng-Cong Li; Xu Zhang; Bin Pei; Li-Xin Jiao; Gang Shen; Ying Liu; Zhi-Hui Feng; Yu-Ping Su; Zhao-Xia Xu; Wen-Ying Di; Yao-Qin Jiang; Hong-Lei Fu; Xiang-Jun Liu; Xiang Liu; Mei-Zhen Zhou; Dan Du; Qi Liu; Ying Han; Zhi-Xin Zhang; Jian-Ping Cai
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

5.  HLA-DRB1 and DQB1 genetic susceptibility to pemphigus vulgaris and pemphigus foliaceus in Vietnamese patients.

Authors:  The Bich Thanh Vuong; Duc Minh Do; Phuc Thinh Ong; Thai Van Thanh Le
Journal:  Dermatol Reports       Date:  2021-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.